Advertisement

Topics

Zafgen, Inc. Company Profile

06:46 EDT 21st June 2018 | BioPortfolio

Zafgen is pioneering novel obesity therapeutics that directly target fat metabolism to help the body regain and sustain a lean, healthy state. The company’s approach focuses on restoring control of key metabolic processes, releasing stored fat which then is used by the body as fuel. Zafgen’s first generation product, named ZGN-433, is being studied in a Phase 1b clinical trial for its use as a pharmacological alternative to bariatric surgery in the treatment of severe obesity. Zafgen's leadership and scientific advisors include leading experts in obesity, metabolic disorders and medicinal chemistry. Founded in 2005, the company is located in Cambridge, Mass. For more information, visit www.zafgen.com.


News Articles [24 Associated News Articles listed on BioPortfolio]

Zafgen tries again with obesity, rare disease drugs after setback

After a shrinking of a few years ago, Zafgen's stock grows in diabetes and obesity news.

Why Zafgen's Upcoming Catalyst Is So Important

Management tracks: Zafgen, Rigel

Zafgen's Pipeline Takes A Substantial De-Risking Step

Zafgen Reports First Quarter 2018 Operating and Financial Results

Multiple ZGN-1061 abstracts accepted for presentation at upcoming American Diabetes Association (ADA) Scientific Sessions ZGN-1061 Phase 1 SAD / MAD data published in Diabetes, Obesity and Metaboli...

Zafgen: Second-Generation MetAP2 Inhibitors Likely To Unlock Substantial Intermediate Value

Zafgen to Present at Cowen 38th Annual Health Care Conference

BOSTON, March 07, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel ...

Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference

BOSTON, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel th...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Zafgen, Inc.

Zafgen is pioneering novel obesity therapeutics that directly target fat metabolism to help the body regain and sustain a lean, healthy state. The company’s approach focuses ...

More Information about "Zafgen, Inc." on BioPortfolio

We have published hundreds of Zafgen, Inc. news stories on BioPortfolio along with dozens of Zafgen, Inc. Clinical Trials and PubMed Articles about Zafgen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zafgen, Inc. Companies in our database. You can also find out about relevant Zafgen, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record